Spirepoint Private Client LLC has acquired a $575,000 position in
Analog Devices, Inc. (ADI) while the company sees a short-term dip as the market gains. Despite daily losses compared to competitors, ADI's stock continues its positive trend, pleasing large institutional owners.
Cantor Fitzgerald reaffirmed ADI's stock rating and Barclays raised the PT to $250.00. However, near-term pressures are expected. Revenue and earnings growth for ADI is being predicted by some experts as
Analog Devices leverage the start of a cyclical recovery. An upbeat report was shared by the chipmaker while experts provided insight into the company's robust Q2 financial results. Despite showing more significant dips than the broader market, ADI rose in Q2. Institutional investors show a significant interest in ADI owning 88% of the company. ADI forecasts a strong business recovery in the chip market and is increasing their partnership with TSMC to strengthen capacity and resilience. Despite inconsistent financials, the stock performance remains strong.
U.S. FDA gives 510(k) clearance to ADI's Sensinel by Analog Devices™ Cardiopulmonary Management (CPM) System.
BMW partnered with ADI to deliver 10MB Ethernet service to vehicles. Although there are warnings of continued weak sales, ADI's dividend analysis and cyclical risk are reported neutrally.
Analog Devices ADI News Analytics from Tue, 21 Nov 2023 08:00:00 GMT to Sun, 21 Jul 2024 20:41:08 GMT -
Rating 7
- Innovation 6
- Information 6
- Rumor -2
